Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

NCT05642572 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Capmatinib
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Osimertinib
BIOLOGICAL: Ramucirumab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]